Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment

Vaccine

Volumn 33, Issue 49, 2015, Pages 6955-6966

  Reperant, Leslie A ^a   Grenfell, Bryan T ^b,c   Osterhaus, Albert D M E ^a,d  

^a Artemis One Health   (Netherlands)

^b PRINCETON UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Evolution; Latin hypercube sampling; Mutation; Pandemic; Probabilistic model; Reassortment

Indexed keywords

ARTICLE; GENETIC REASSORTMENT; GENOTYPE; HUMAN; INFECTION RISK; INFLUENZA A; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIROGENESIS; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; GENETICS; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA A VIRUS; MOLECULAR EVOLUTION; MUTATION; ORTHOMYXOVIRUS INFECTION; PANDEMIC; PHYSIOLOGY; RISK FACTOR; THEORETICAL MODEL; VIROLOGY; ZOONOSIS;

ANIMALS; COINFECTION; EVOLUTION, MOLECULAR; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, THEORETICAL; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; REASSORTANT VIRUSES; RISK FACTORS; VIRUS REPLICATION; ZOONOSES;

EID: 84951310130     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.056     Document Type: Article

References (56)

1. Taubenberger J.K., Kash J.C. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010, 7(6):440-451.
2. Reperant L.A., Kuiken T., Osterhaus A.D. Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans. Vaccine 2012, 30(30):4419-4434.
3. Drake J.W. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A 1993, 90(9):4171-4175.
4. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453(7195):615-619.
5. Sorrell E.M., Wan H., Araya Y., Song H., Perez D.R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A 2009, 106(18):7565-7570.
6. Imai K., Nakamura K., Mase M., Tsukamoto K., Imada T., Yamaguchi S. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012, 486(7403):420-428.
7. Zhang Y., Zhang Q., Kong H., Jiang Y., Gao Y., Deng G., et al. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet. Science 2013, 340(6139):1459-1463.
8. Kimble J.B., Angel M., Wan H., Sutton T.C., Finch C., Perez D.R. Alternative reassortment events leading to transmissible H9N1 influenza viruses in the ferret model. J Virol 2014, 88:66-71.
9. Herfst S., Schrauwen E.J., Linster M., Chutinimitkul S., de Wit E., Munster V.J., et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012, 336(6088):1534-1541.
10. Zhang Q., Shi J., Deng G., Guo J., Zeng X., He X., et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 2013, 341(6144):410-414.
11. Linster M., van Boheemen S., de Graaf M., Schrauwen E.J., Lexmond P., Manz B., et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell 2014, 157(2):329-339.
12. Sutton T.C., Finch C., Shao H., Angel M., Chen H., Capua I., et al. Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets. J Virol 2014, 88(12):6623-6635.
13. Russell C.A., Fonville J.M., Brown A.E., et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012, 336(6088):1541-1547.
14. Lloyd-Smith J.O., George D., Pepin K.M., et al. Epidemic dynamics at the human-animal interface. Science 2009, 326(5958):1362-1367.
15. Wikramaratna P.S., Kucharski A., Gupta S., Andreasen V., McLean A.R., Gog J.R. Five challenges in modelling interacting strain dynamics. Epidemics 2015, 10:31-34.
16. Dushoff J., Plotkin J.B., Levin S.A., Earn D.J. Dynamical resonance can account for seasonality of influenza epidemics. Proc Natl Acad Sci U S A 2004, 101(48):16915-16916.
17. Ferguson N.M., Galvani A.P., Bush R.M. Ecological and immunological determinants of influenza evolution. Nature 2003, 422(6930):428-433.
18. Koelle K., Cobey S., Grenfell B., Pascual M. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006, 314(5807):1898-1903.
19. Koelle K., Kamradt M., Pascual M. Understanding the dynamics of rapidly evolving pathogens through modeling the tempo of antigenic change: influenza as a case study. Epidemics 2009, 1(2):129-137.
20. Koelle K., Khatri P., Kamradt M., Kepler T.B. A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface 2010, 7(50):1257-1274.
21. Axelsen J.B., Yaari R., Grenfell B.T., Stone L. Multiannual forecasting of seasonal influenza dynamics reveals climatic and evolutionary drivers. Proc Natl Acad Sci U S A 2014, 111(26):9538-9542.
22. Ferguson N.M., Cummings D.A., Cauchemez S., Fraser C., Riley S., Meeyai A., et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005, 437(7056):209-214.
23. Longini I.M., Halloran M.E., Nizam A., Yang Y. Containing pandemic influenza at the source. Science 2005, 309(5737):1083-1087.
24. Kubiak R.J., Arinaminpathy N., McLean A.R. Insights into the evolution and emergence of a novel infectious disease. PLoS Comput Biol 2010, 6(9).
25. Reperant L.A., Kuiken T., Grenfell B.T., Osterhaus A.D. The immune response and within-host emergence of pandemic influenza virus. Lancet 2008, 834(7):2077-2081.
26. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167(7):775-785.
27. Nakajima N., Van Tin N., Sato Y., Thach H.N., Katano H., Diep P.H., et al. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Modern Pathol: Off J US Can Acad Pathol Inc. 2013, 26(3):357-369.
28. Zhou J.J., Fang D.Y., Fu J., Tian J., Zhou J.M., Yan H.J., et al. Infection and replication of avian influenza H5N1 virus in an infected human. Virus Genes 2009, 39(1):76-80.
29. Sirinonthanawech N., Uiprasertkul M., Suptawiwat O., Auewarakul P. Viral load of the highly pathogenic avian influenza H5N1 virus in infected human tissues. J Med Virol 2011, 83(8):1418-1423.
30. van der Vries E., Stittelaar K.J., van Amerongen G., Veldhuis Kroeze E.J., de Waal L., Fraaij P.L., et al. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog 2013, 9(5):e1003343.
31. Rimmelzwaan G.F., Baars M., Claas E.C., Osterhaus A.D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 1998, 74(1):57-66.
32. Nowak M.A., May R.M. Virus dynamics: mathematical principles of immunology and virology 2000, Oxford University Press, Oxford.
33. Murcia P.R., Baillie G.J., Daly J., Elton D., Jervis C., Mumford J.A., et al. Intra- and interhost evolutionary dynamics of equine influenza virus. J Virol 2010, 84(14):6943-6954.
34. Murcia P.R., Hughes J., Battista P., Lloyd L., Baillie G.J., Ramirez-Gonzalez R.H., et al. Evolution of an Eurasian avian-like influenza virus in naive and vaccinated pigs. PLoS Pathog 2012, 8(5):e1002730.
35. Massin P., van der Werf S., Naffakh N. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol 2001, 75(11):5398-5404.
36. Gabriel G., Abram M., Keiner B., Wagner R., Klenk H.D., Stech J. Differential polymerase activity in avian and mammalian cells determines host range of influenza virus. J Virol 2007, 81(17):9601-9604.
37. Antia R., Regoes R.R., Koella J.C., Bergstrom C.T. The role of evolution in the emergence of infectious diseases. Nature 2003, 426(6967):658-661.
38. Marshall N., Priyamvada L., Ende Z., Steel J., Lowen A.C. Influenza virus reassortment occurs with high frequency in the absence of segment mismatch. PLoS Pathog 2013, 9(6):e1003421.
39. Bodewes R., Nieuwkoop N.J., Verburgh R.J., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F. Use of influenza A viruses expressing reporter genes to assess the frequency of double infections in vitro. J Gen Virol 2012, 93(Pt 8):1645-1648.
40. Tao H., Steel J., Lowen A.C. Intrahost dynamics of influenza virus reassortment. J Virol 2014, 88(13):7485-7492.
41. Molinari N.A., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25(27):5086-5096.
42. Wu J.T., Ma E.S., Lee C.K., Chu D.K., Ho P.L., Shen A.L., et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51(10):1184-1191.
43. Lemaitre M., Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010, 10:162.
44. Blower S.M., Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int Stat Rev/Revue Internationale de Statistique 1994, 62(2). 229-43 CR.
45. Minasny B., McBratney A.B. A conditioned Latin hypercube method for sampling in the presence of ancillary information. Computers Geosci 2006, 32(9):1378-1388.
46. Chen J.M., Chen J.W., Dai J.J., Sun Y.X. A survey of human cases of H5N1 avian influenza reported by the WHO before June 2006 for infection control. Am J Infect Control 2007, 35(7):467-469.
47. To K.K., Chan J.F., Chen H., Li L., Yuen K.Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013, 13(9):809-821.
48. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9(8):493-504.
49. Uyeki T.M. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009, 49(2):279-290.
50. Gao H.N., Lu H.Z., Cao B., Du B., Shang H., Gan J.H., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013, 368(24):2277-2285.
51. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997, 51:151-178.
52. Reperant L.A., Kuiken T., Grenfell B.T., Osterhaus A.D.M.E., Dobson A.P. Linking influenza virus tissue tropism to population-level reproductive fitness. PLoS ONE 2012, 7(8):e43115.
53. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358(3):261-273.
54. Xiong X., Martin S.R., Haire L.F., Wharton S.A., Daniels R.S., Bennett M.S., et al. Receptor binding by an H7N9 influenza virus from humans. Nature 2013, 499(7459):496-499.
55. ProMED-mail. Avian Influenza, human (10): Canada ex China (Beijing) H5N1, Fatal 2014; 20140108.2160514.
56. ProMED-mail. Avian Influenza, Human (23): China (Guangdong) H7N9, Canada first case. 2015; 20150126.3120361.